New understanding and approaches to treatment in rheumatoid arthritis
Identifieur interne : 001639 ( Main/Exploration ); précédent : 001638; suivant : 001640New understanding and approaches to treatment in rheumatoid arthritis
Auteurs : Jean H. Tayar ; Maria E. Suarez-Almazor [États-Unis]Source :
- British Medical Bulletin [ 0007-1420 ] ; 2010.
Abstract
Rheumatoid arthritis (RA) is the most common autoimmune inflammatory polyarthritis. Significant advances in the understanding of its pathogenesis have led in the past two decades to major advancement in its therapy. We used data from articles in Cochrane Database of Systematic Reviews on ‘rheumatoid arthritis’, meta-analyses and randomized controlled trials on adult RA (age >19 years) published in English within the past 5 years and identified in PubMed, and other key papers on management of RA. Appropriate, early and aggressive therapy is required for confirmed active cases of RA. The choice of disease-modifying drugs and different combinations, especially the newer biologic agents in regards of their early and long-term usage remains debated because of high costs and long-term safety concerns. Development of newer biologic agents working on different pathways of inflammation is underway in different stages. It remains to be determined how and when each of these agents will fit in the overall management of RA. Furthermore, post-marketing surveillance of the safety and response sustainability of these drugs is warranted.
Url:
DOI: 10.1093/bmb/ldq007
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001095
- to stream Istex, to step Curation: 001095
- to stream Istex, to step Checkpoint: 000584
- to stream Main, to step Merge: 001642
- to stream Main, to step Curation: 001639
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>New understanding and approaches to treatment in rheumatoid arthritis</title><author><name sortKey="Tayar, Jean H" sort="Tayar, Jean H" uniqKey="Tayar J" first="Jean H." last="Tayar">Jean H. Tayar</name></author><author><name sortKey="Suarez Almazor, Maria E" sort="Suarez Almazor, Maria E" uniqKey="Suarez Almazor M" first="Maria E." last="Suarez-Almazor">Maria E. Suarez-Almazor</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:775C2EF3E5500D9A90207C0AA56B370DC20BEF18</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1093/bmb/ldq007</idno><idno type="url">https://api.istex.fr/ark:/67375/HXZ-N6N5H65L-Q/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001095</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001095</idno><idno type="wicri:Area/Istex/Curation">001095</idno><idno type="wicri:Area/Istex/Checkpoint">000584</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000584</idno><idno type="wicri:doubleKey">0007-1420:2010:Tayar J:new:understanding:and</idno><idno type="wicri:Area/Main/Merge">001642</idno><idno type="wicri:Area/Main/Curation">001639</idno><idno type="wicri:Area/Main/Exploration">001639</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">New understanding and approaches to treatment in rheumatoid arthritis</title><author><name sortKey="Tayar, Jean H" sort="Tayar, Jean H" uniqKey="Tayar J" first="Jean H." last="Tayar">Jean H. Tayar</name><affiliation></affiliation><affiliation><wicri:noCountry code="subField">JHtayar@mdanderson.org</wicri:noCountry></affiliation></author><author><name sortKey="Suarez Almazor, Maria E" sort="Suarez Almazor, Maria E" uniqKey="Suarez Almazor M" first="Maria E." last="Suarez-Almazor">Maria E. Suarez-Almazor</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of General Internal Medicine, AT and EC, Section of Rheumatology, The University of Texas M D Anderson Cancer Center, Houston, TX</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">British Medical Bulletin</title><idno type="ISSN">0007-1420</idno><idno type="eISSN">1471-8391</idno><imprint><publisher>Oxford University Press</publisher><date when="2010-06">2010</date><date type="e-published" when="2010-03-02">2010</date><biblScope unit="vol">94</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="201">201</biblScope><biblScope unit="page" to="214">214</biblScope></imprint><idno type="ISSN">0007-1420</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0007-1420</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">Rheumatoid arthritis (RA) is the most common autoimmune inflammatory polyarthritis. Significant advances in the understanding of its pathogenesis have led in the past two decades to major advancement in its therapy. We used data from articles in Cochrane Database of Systematic Reviews on ‘rheumatoid arthritis’, meta-analyses and randomized controlled trials on adult RA (age >19 years) published in English within the past 5 years and identified in PubMed, and other key papers on management of RA. Appropriate, early and aggressive therapy is required for confirmed active cases of RA. The choice of disease-modifying drugs and different combinations, especially the newer biologic agents in regards of their early and long-term usage remains debated because of high costs and long-term safety concerns. Development of newer biologic agents working on different pathways of inflammation is underway in different stages. It remains to be determined how and when each of these agents will fit in the overall management of RA. Furthermore, post-marketing surveillance of the safety and response sustainability of these drugs is warranted.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Texas</li></region></list><tree><noCountry><name sortKey="Tayar, Jean H" sort="Tayar, Jean H" uniqKey="Tayar J" first="Jean H." last="Tayar">Jean H. Tayar</name></noCountry><country name="États-Unis"><region name="Texas"><name sortKey="Suarez Almazor, Maria E" sort="Suarez Almazor, Maria E" uniqKey="Suarez Almazor M" first="Maria E." last="Suarez-Almazor">Maria E. Suarez-Almazor</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001639 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001639 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:775C2EF3E5500D9A90207C0AA56B370DC20BEF18
|texte= New understanding and approaches to treatment in rheumatoid arthritis
}}
| This area was generated with Dilib version V0.6.33. |  |